Skip to main content
Caplight Logo









SaileGene

SaileGene

Private
BeijingHealthcare & Life Scienceshttp://sailegene.com/

Last Round

Angel

Jan 1, 2019

Total Funding Raised

$1.45M

Company Overview

SaileGene is a biotechnology company that provides high-speed, high-precision, and cost-effective bioinformatics data analysis solutions through its BaseNumber NGS platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

genomic testingmolecular diagnosticsbioinformaticsnext-generation sequencingNGSgenomic sequencingprecision medicinebioinformatics softwaregenomicsbiotech researchgenomic data analysislab servicesbioinformatics pipelinebiotech labgenomic platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SaileGene Comparables

Compare SaileGene with similar companies based on industry and business-model similarity.

SaileGene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Annoroad Gene Technology
81%
Beijing Geneplus Technology
74%
GeneDock
74%

SaileGene Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 1, 2019

SaileGene Investors

Notable investors and investment history

SaileGene investors
InvestorRounds
New Potential Energy FundAngel
Meihua Venture CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2019

    $1.45M raised from Meihua Venture Capital and New Potential Energy Fund.

SaileGene Filings

Explore SEC and related filing metadata, where available.

SaileGene filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SaileGene's valuation, stock price, and market status.

Is SaileGene a public or private company?

SaileGene is a private company.

What is the current stock price of SaileGene?

SaileGene is a private company with no public stock price. Caplight tracks SaileGene's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is SaileGene worth (valuation)?

Valuation information for SaileGene is not publicly available.

Can I buy SaileGene stock?

SaileGene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SaileGene's last funding round?

SaileGene's most recent funding round was Angel on January 1, 2019.

Who are the main investors in SaileGene?

Key investors in SaileGene include New Potential Energy Fund, Meihua Venture Capital.

Will SaileGene IPO soon?

No public IPO plans have been announced for SaileGene.

How can I track SaileGene secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SaileGene's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2018
Last FundingJan 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?